Abstract:OBJECTIVETo evaluate the clinical and angiographic outcomes of vasospastic angina patients with severe organic stenosis treated by drug-eluting stents.METHODSBetween January 2006 and December 2010, severe organic stenosis (diameter stenosis more than 70%) was evidenced in 7 out of 46 vasospastic angina patients and treated with drug-eluting stents. Coronary angiography was repeated at 6 - 18 months after percutaneous coronary intervention and the patients were clinically followed up. The clinical and angiographic outcomes were observed.RESULTSNine drug-eluting stents [mean diameter 2.75 - 3.50 (3.08 ± 0.24) mm, length 24 - 33 (27.3 ± 3.6) mm] were successfully implanted in these 7 patients. Stents were implanted into left anterior descending artery (LAD) in 5 patients (71.4%), right coronary artery (RCA) in 1 patient (14.3%), both LAD and RCA in 1 patient (14.3%). Transient RCA spasm and distal LAD spasm were observed during percutaneous coronary intervention of LAD in 2 patients. Anginal attack at rest with transient ST segment elevation at V(1)-V(3) leads occurred 24 hours after LAD stenting in 1 patient. Follow-up coronary angiography showed significant in-stent restenosis or focal edge restenosis (diameter stenosis more than 50%) in 3 patients (42.9%), mild neointimal proliferation but without significant restenosis in 2 patients (28.6%), and no neointimal proliferation in 2 patients (28.6%). During clinical follow-up of 17 to 50 months after percutaneous coronary intervention, 2 patients (28.6%) remained asymptomatic, while effort angina and/or rest angina was documented in the remaining 5 patients (71.4%).CONCLUSIONSOur results from this small patient cohort suggest that drug eluting stent implantation for severe organic stenosis in patients with vasospastic angina is linked with high incidence of restenosis and recurrent chest pain. Further observation in larger patient cohort is warranted to clarify the efficacy of this strategy for treating vasospastic angina patients with severe organic stenosis.

Drug-eluting stent for treatment of symptomatic vertebral artery origin stenosis

Drug-Eluting Stent for the Treatment of Symptomatic Vertebral Artery Stenosis

Cause Analysis and Treatment of Vertebral Artery Stenosis Angioplasty Restenosis

Application of drug-eluting stent for the treatment of symptomatic vertebral artery stenosis

Endovascular Revascularization of Chronically Occluded Vertebral Artery: Single-Center Experience.

Endovascular recanalization for chronic symptomatic intracranial vertebral artery total occlusion.

Drug-eluting stent for the treatment of symptomatic vertebral origin stenosis

The Long Term Results Of Vertebral Artery Ostium Stenting In A Single Center

Drug-eluting Stent for the Treatment of Symptomatic Vertebral Origin Stenosis: Long-term Results

Stenting of symptomatic vertebral artery ostium stenosis with self-expanding stents.

Self-expanding carotid stent for the treatment of moderate to severe stenosis at the origin of vertebral artery: an efficacy analysis

Endovascular Stenting for Treatment of Vertebral Arterial Stenosis

A Comparison of Different Endovascular Treatment for Vertebral Artery Origin Stenosis.

Stent Placement for the Treatment of Symptomatic Severe Stenotic or Occluded Subclavian Arterial Lesions

[Safety and Short-Term Results of Stent-Assisted Angioplasty for the Treatment of Intracranial Arterial Stenosis].

Safety and Efficacy of Rapamycin-Eluting Vertebral Stents in Patients With Symptomatic Extracranial Vertebral Artery Stenosis

Endovascular stenting for vertebral artery stenosis

Endovascular Stenting for Symptomatic Stenosis of Middle Cerebral Artery

[Clinical and Angiographic Outcomes of Coronary Drug-Eluting Stenting in Treating Vasospastic Angina Patients with Severe Organic Stenosis].

Endovascular Treatment of Symptomatic Intracranial Atherosclerotic Stenosis with Low Profile Visualized Intraluminal Support Stent.

Intraluminal Stent Placement Treats Symptomatic Proximal Vertebral Artery Stenosis